HealthCor Management’s Envista NVST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-914,490
Closed -$44.5M 68
2022
Q1
$44.5M Sell
914,490
-728,190
-44% -$33.6M 2.97% 12
2021
Q4
$74M Sell
1,642,680
-607,292
-27% -$25M 4.03% 5
2021
Q3
$94.1M Buy
2,249,972
+1,084,112
+93% +$45.7M 4.06% 7
2021
Q2
$50.4M Sell
1,165,860
-269,510
-19% -$11.7M 2.01% 20
2021
Q1
$58.6M Buy
1,435,370
+396,080
+38% +$15.1M 2.07% 20
2020
Q4
$35.1M Buy
+1,039,290
New +$30.1M 1.35% 26
2020
Q2
Sell
-888,210
Closed -$13.3M 59
2020
Q1
$13.3M Sell
888,210
-1,957,940
-69% -$50.1M 0.57% 42
2019
Q4
$84.4M Buy
2,846,150
+2,546,150
+849% +$72.4M 3.01% 13
2019
Q3
$8.36M Buy
+300,000
New +$8.38M 0.32% 45

Other funds holding NVST

HealthCor Management's NVST Position: Q2 2022 in Review

HealthCor Management sold out of Envista (NVST) in Q2 2022, closing a stake of 914,490 shares — an estimated $44.5M sold.

HealthCor Management first reported a position in NVST in Q3 2019 and held it in 9 quarters. The position peaked at $94.1M in Q3 2021. 339 funds tracked by Wall St. Rank hold NVST as of Q2 2022.

  • HealthCor Management reported no remaining Envista position as of Q2 2022 after selling out during the quarter.
  • HealthCor Management sold 914,490 Envista shares in Q2 2022, an estimated $44.5M.
  • HealthCor Management first reported a position in Envista in Q3 2019 and held it in 9 quarters.
  • HealthCor Management's Envista position peaked at $94.1M in Q3 2021.
  • 339 funds tracked by Wall St. Rank held Envista as of Q2 2022.

Based on HealthCor Management's 13F filing for Q2 2022, filed 15 Aug 2022.